These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2512832)

  • 21. [Pseudomonas multicomponent vaccine in major burn patients].
    Mizuno H; Ashikawa K
    Nihon Rinsho; 1991 Oct; 49(10):2425-30. PubMed ID: 1749100
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arthritis in burned persons, caused by Pseudomonas aeruginosa].
    Orlov AN; Baliabin AA; Krasnopevtseva OS
    Vestn Khir Im I I Grek; 1975 Nov; 115(11):98-100. PubMed ID: 813351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
    Ullah F; Malik SA; Ahmed J
    Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Pseudomonas aeruginosa biomarkers from thermally injured mice in situ using imaging mass spectrometry.
    Hamerly T; Everett JA; Paris N; Fisher ST; Karunamurthy A; James GA; Rumbaugh KP; Rhoads DD; Bothner B
    Anal Biochem; 2017 Dec; 539():144-148. PubMed ID: 29107579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nosocomial transmission of carbapenem-resistant Pseudomonas aeruginosa among burn patients.
    Maillet M; Pelloux I; Forli A; Vancoetsem K; Cheong Sing JS; Marfaing S; Ducki S; Batailler P; Mallaret MR
    Infect Control Hosp Epidemiol; 2014 May; 35(5):597-9. PubMed ID: 24709737
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacterial virulence genes lead double life.
    Wuethrich B
    Science; 1995 Jun; 268(5219):1850. PubMed ID: 7604256
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of surface swab cultures and quantitative tissue biopsy cultures to predict sepsis in burn patients: a prospective study.
    Sjöberg T; Mzezewa S; Jönsson K; Robertson V; Salemark L
    J Burn Care Rehabil; 2003; 24(6):365-70. PubMed ID: 14610420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
    Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
    Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology of infection with Pseudomonas pyocyanea in a burns unit.
    LOWBURY EJ; FOX J
    J Hyg (Lond); 1954 Sep; 52(3):403-16. PubMed ID: 13212044
    [No Abstract]   [Full Text] [Related]  

  • 30. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pseudomonas aeruginosa infection in burn patients].
    Orlov AN
    Khirurgiia (Mosk); 1979 Aug; (8):7-10. PubMed ID: 502283
    [No Abstract]   [Full Text] [Related]  

  • 32. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns.
    Holder IA; Neely AN; Frank DW
    Burns; 2001 Mar; 27(2):129-30. PubMed ID: 11226648
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCR-based assay for the rapid and precise distinction of Pseudomonas aeruginosa from other Pseudomonas species recovered from burns patients.
    Gholami A; Majidpour A; Talebi-Taher M; Boustanshenas M; Adabi M
    J Prev Med Hyg; 2016; 57(2):E81-5. PubMed ID: 27582633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of granulocyte and platelet production by pseudomonas burn wound infection.
    Newsome TW; Eurenius K
    Surg Gynecol Obstet; 1973 Mar; 136(3):375-9. PubMed ID: 4631850
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran.
    Asadpour L
    J Glob Antimicrob Resist; 2018 Jun; 13():214-220. PubMed ID: 29421318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
    Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
    Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome Analysis of
    Gonzalez MR; Ducret V; Leoni S; Fleuchot B; Jafari P; Raffoul W; Applegate LA; Que YA; Perron K
    Front Cell Infect Microbiol; 2018; 8():39. PubMed ID: 29535973
    [No Abstract]   [Full Text] [Related]  

  • 40. [An experimental study of antibiotic -- induced endotoxin release in Pseudomonas aeruginosa bacteremia inburned rats].
    Wang S; Wu B; Huang F
    Zhonghua Shao Shang Za Zhi; 2000 Apr; 16(2):93-5. PubMed ID: 11876851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.